当前位置:主页 > 医学论文 > 泌尿论文 >

The PI3K/AKT Pathway and Renal Cell Carcinoma

发布时间:2022-05-08 09:47
  The phosphatidylinositol 3 kinase(PI3K)/AKT pathway is genetically targeted in more pathway components and in more tumor types than any other growth factor signaling pathway,and thus is frequently activated as a cancer driver.More importantly,the PI3K/AKT pathway is composed of multiple bifurcating and converging kinase cascades,providing many potential targets for cancer therapy.Renal cell carcinoma(RCC) is a high-risk and high-mortality cancer that is notoriously resistant to traditional chemo... 

【文章页数】:11 页

【文章目录】:
INTRODUCTION
THE PI3K/AKT PATHWAY
    PI3K and upstream regulators
    AKT and downstream effectors
GENETIC ALTERATIONS OF THE PI3K/AKT PATHWAY IN CANCER
GENETIC ALTERATIONS OF THE PI3K/AKT PATHWAY IN RCC
    The PI3K/AKT pathway in ccRCC
    The PI3K/AKT pathway in pRCC
    The PI3K/AKT pathway in chRCC
ADDITIONAL MECHANISMS ACTIVATING THE P13K/AKT PATHWAY IN RCC
TARGETING THE PI3K/AKT PATHWAY IN RCC
CONCLUDING REMARKS



本文编号:3651425

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/mjlw/3651425.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户d237e***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com